20 (AIDX) Depreciation & Amortization (CF) (2025 - 2026)
20 posted quarterly Depreciation & Amortization (CF) of $12306.0 for Q1 2026, down 30.96% year-on-year from $17825.0 in Q1 2025, and down 30.96% on a QoQ basis from $17825.0 in Q1 2025.
20 (AIDX) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $12306.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 30.96% year-over-year to $12306.0; the trailing twelve-month figure through Mar 2026 stood at $30131.0 (changed N/A YoY), and the FY2025 full-year result was $63257.0, down 45.48% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $12306.0, down from $17825.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $17825.0 in Q1 2025 and bottomed at $12306.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | 20 | - | - | 62,884.00 | 12,306.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,306.00 |
| Mar 31, 2026 | 12,306.00 |
| Mar 31, 2025 | 17,825.00 |
| Mar 31, 2025 | 17,825.00 |